BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20240430T100000
DTEND;TZID=Europe/London:20240430T130000
DTSTAMP:20260408T085711
CREATED:20240319T112016Z
LAST-MODIFIED:20240501T110301Z
UID:29345-1714471200-1714482000@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: Planning Ahead for Clinical Evidence
DESCRIPTION:  \n \nJoin Medilink and partner Afortiori Development for an in-person event which will be about planning ahead for clinical evidence and preparing adequately for this.\nThe event will cover:\n\nPart 1: Introduction to Commercial Clinical Development. What is a clinical development plan? Why do I need one?\nPart 2: Trials and trial design considerations \, Regulatory requirements & guidelines\, ethical considerations\, trial set up\, trial oversight\, site selection\, systems requirements\nPart 3: Trial oversight\, patient recruitment\, quality assurance\, safety monitoring\, trial data reporting\n\n  \nKey Objectives for attendees:\n\nKnow what your Sponsor responsibilities are where a trial is concerned\nBe clear about what happens and when in planning and undertaking a clinical trial\nIdentifying preliminary project timelines for any project and be able to see how various changes impact overall timelines\n\n  \nSpeaker information\n \nDr. Nicola Wall\, PhD and  Chief Executive Officer at Afortiori Development Ltd\nNicola founded Afortiori Development to address the need for improved clinical trial design\, planning and management to promote efficient and cost effective clinical trials. She has an exceptional background within the pharmaceutical\, medical technology and healthcare sectors with over 20 years of diverse experience. She has managed multiple projects across a range of therapeutic areas for a number of large and small clients spanning all areas of clinical development including regulatory\, data management\, safety\, quality and organisational effectiveness. Nicola has also managed global clinical trials in Oncology and Neurology with responsibility for 29 countries across the entire clinical trial process. She excels in strategic planning\, process re-engineering\, systems implementation and organisational design. She has also worked for a number of years as an independent consultant for the UK national health service working on hospital operational planning\, business cases and ways to implement new models of care.\nNicola is passionate in her desire to work with highly motivated and respected peers in addressing unmet medical need. Nicola believes that integrity\, transparency and efficiency combined with experience and motivation results in the most successful projects and clinical studies.\nShe attained all three of her degrees at the University of Manchester in the UK including her PhD in Economics that focused on patterns of innovation in the pharmaceutical Industry. \n  \n\nLiz Ralph\, BSc and Chief Operating Officer at Afortiori Development Ltd\nLiz has worked in a variety of roles in the industry for over 20 years across clinical operations groups in a global CRO environment. She has monitored and managed a large number of clinical trials in all phases\, healthcare settings and a number of countries before moving to a quality\, process and training role\, which included experience of regulatory inspections. This allowed her to develop a sound and extensive knowledge base to foster a strong embedded quality culture with a focus on continual process innovation and effective training for those working in clinicaloperations roles.\nLiz has additional valuable experience in patient perspectives of participation in clinical trials gained whilst working in a large UK Clinical Research Facility actively delivering hundreds of clinical studies across 2 hospital sites in a large UK teaching hospital. During this time she led in patient and public involvement in clinical research for the Facility and worked nationally as part of a UK wide patient and public involvement network which aimed to ensure that patient and carer voices are prominent in research delivery in the National Health Service in the UK.\nLiz is committed to designing and delivering clinical research with the potential to add significant value to the lives of patients and their families by developing accessible treatments for unmet clinical need. \n  \n \nHelen Hunt\, Assistant Programme Manager – Knowledge Mobilisation at Health Innovation West Midlands\nHelen has worked for Health Innovation West Midlands for 8 years and previous to that she has worked as an operational manager in the NHS acute care setting for 16 years.   During her tenure\, she has undertaken multiple roles\, starting with frontline patient-facing positions right up to senior management positions overseeing large departments. These positions have covered a large cross-section of NHS landscape including cancer services\, operational management\, health informatics and R&D. Helen is a trained Prince 2 practitioner\, with her post graduate certification in Health Management specialising in Quality Improvement & Patient Safety.  She is passionate about connecting people through knowledge mobilisation to allow real world evidence to be generated. \n  \nTo read more about Medilink Midlands’ role within the WMHTIA project\, click here. \nFor more information on the wider project\, click here to visit the WMHTIA website. \nThis event forms part of the West Midlands Health Tech Innovation Accelerator (WMHTIA) event series. Medilink Midlands are one of a consortium of delivery partners for the WMHTIA\, a project funded by the Department for Science\, Innovation and Technology\, Innovate UK and West Midlands Combined Authority (part of City Regions).
URL:https://staging.medilinkmidlands.com/event/in-person-event-planning-ahead-for-clinical-evidence/
LOCATION:Leonardo Royal Hotel Birmingham\, 245 Broad Street\, Birmingham\, B1 2HQ\, United Kingdom
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Linsey Horsepool Medilink Midlands":MAILTO:events@medilinkmidlands.com
END:VEVENT
END:VCALENDAR